Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31551 - 31575 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	DDIT3	1649	downregulated	Cisplatin results in decreased expression of DDIT3 mRNA	12q13.3	A22204
Cisplatin	Approved Investigational	DDIT3	1649	upregulated	Cisplatin results in increased expression of DDIT3 mRNA	12q13.3	A22246 A22241 A20427
Cisplatin	Approved Investigational	DDIT4	54541	downregulated	Cisplatin results in decreased expression of DDIT4 mRNA	10q22.1	A21499
Cisplatin	Approved Investigational	DDIT4	54541	upregulated	Cisplatin results in increased expression of DDIT4 mRNA	10q22.1	A22212 A20427
Cisplatin	Approved Investigational	DDX17	10521	downregulated	Cisplatin results in decreased expression of DDX17 mRNA	22q13.1	A20427
Cisplatin	Approved Investigational	DDX24	57062	upregulated	Cisplatin results in increased expression of DDX24 mRNA	14q32.12	A20427
Cisplatin	Approved Investigational	DENND1A	57706	downregulated	Cisplatin results in decreased expression of DENND1A mRNA	9q33.3	A22204
Cisplatin	Approved Investigational	DFFB	1677	downregulated	Cisplatin results in decreased expression of DFFB mRNA	1p36.32	A22203
Cisplatin	Approved Investigational	DFFB	1677	upregulated	Cisplatin results in increased expression of DFFB mRNA	1p36.32	A22237
Cisplatin	Approved Investigational	DGKA	1606	upregulated	Cisplatin results in increased expression of DGKA mRNA	12q13.2	A22203 A20427
Cisplatin	Approved Investigational	DHCR7	1717	downregulated	Cisplatin results in decreased expression of DHCR7 mRNA	11q13.4	A22203
Cisplatin	Approved Investigational	DHRS2	10202	downregulated	Cisplatin results in decreased expression of DHRS2 mRNA	14q11.2	A22204
Cisplatin	Approved Investigational	DIAPH2	1730	downregulated	Cisplatin results in decreased expression of DIAPH2 mRNA	Xq21.33	A22204
Cisplatin	Approved Investigational	DLGAP5	9787	downregulated	Cisplatin results in decreased expression of DLGAP5 mRNA	14q22.3	A20427
Cisplatin	Approved Investigational	DLX1	1745	downregulated	Cisplatin results in decreased expression of DLX1 mRNA	2q31.1	A20427
Cisplatin	Approved Investigational	DLX2	1746	upregulated	Cisplatin results in increased expression of DLX2 mRNA	2q31.1	A22204
Cisplatin	Approved Investigational	DNAJB11	51726	upregulated	Cisplatin results in increased expression of DNAJB11 mRNA	3q27.3	A22204
Cisplatin	Approved Investigational	DNAJB2	3300	upregulated	Cisplatin results in increased expression of DNAJB2 mRNA	2q35	A20427
Cisplatin	Approved Investigational	DNAJB4	11080	upregulated	Cisplatin results in increased expression of DNAJB4 mRNA	1p31.1	A22204
Cisplatin	Approved Investigational	DOCK1	1793	downregulated	Cisplatin results in decreased expression of DOCK1 mRNA	10q26.2	A22204
Cisplatin	Approved Investigational	DPM3	54344	upregulated	Cisplatin results in increased expression of DPM3 mRNA	1q22	A20427
Cisplatin	Approved Investigational	DPP9	91039	upregulated	Cisplatin results in increased expression of DPP9 mRNA	19p13.3	A20427
Cisplatin	Approved Investigational	DPYD	1806	downregulated	Cisplatin results in decreased expression of DPYD mRNA	1p21.3	A21500
Cisplatin	Approved Investigational	DPYSL3	1809	downregulated	Cisplatin results in decreased expression of DPYSL3 mRNA	5q32	A20427
Cisplatin	Approved Investigational	DRAM1	55332	upregulated	Cisplatin results in increased expression of DRAM1 mRNA	12q23.2	A22205

Displaying entries 31551 - 31575 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability